ARCHIVES

Pharmacogenomics May Lead To Individualized Treatment

This article is from The Cancer Letter archive.

Vol. 27 No. 6 | June 25, 2004

Download PDF Visit The Full Archive

Related Articles

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

ACS Research Grants Hit $78.2 Million

July 18, 1986

Biomedical Panel Says Cancer Panel Should Expand to Serve all NIH

June 4, 1976

Genetics Research Is Prevalent In Central Europe as Scientists Seek Answers To Related Questions

August 16, 1991

National Coalition for Cancer Research Formed To Support Reauthorization, l Research Budgets

April 19, 1985

NIH Changes SBIR/STTG Application Receipt Dates.

February 18, 2000